|
Balkrishna Jahagirdar, M.D.
 Dr. Jahagirdar completed his initial medical training from the King Edward Memorial Hospital in Mumbai, India, followed by a residency in Internal Medicine from University of Illinois, Chicago, where he was inducted into the Alpha-Omega-Alpha Honor Society for his outstanding contributions to patient care and medical education. During his Fellowship in Hematology-Oncology at the University of Minnesota, Dr, Jahagirdar worked on developing new adult stem cell treatments for blood diseases and cancers. His work has been published in high-ranking journals. Dr. Jahagirdar is on the Steering Committee for development of new cancer treatments (Novel Therapeutics) at the North Central Cancer Treatment Group, a national clinical research group sponsored by the National Cancer Institute, based at the Mayo Clinic, Rochester, with participating centers throughout the US and Canada. Dr. Jahagirdar is one of the Board of Directors of the Minnesota Society of Clinical Oncology, whose mission is to provide advocacy for cancer patients and to promote standards of excellence for high-quality cancer care throughout the State of Minnesota. Dr. Jahagirdar is commitment to mentoring the next generation of doctors and has been awarded the Clinical Mentor of the Year Award by his trainees on more than one occasion. TEXTBOOK CHAPTERS Verfaillie CM, Schwartz RE, Jahagirdar B, Jiang Y, Reyes M. Unexpected Potential of Adult Stem Cells. Cellular Therapy: New Frontiers in Transfusion Medicine (First edition; ISBN 3-8055-7629-3, Publisher- American Association of Blood Banks), Editor: Sacher, RA., pages 93-100, Year 2002. Jahagirdar BN, Verfaillie CM. Stem Cell Plasticity. Textbook of Malignant Hematology (2nd Edition; ISBN 1841841455; Publisher- Taylor & Francis Group and Martin Dunitz); Editors: Laurent Degos, David C. Linch and Bob Löwenberg, Year 2004. Journal Publications Jahagirdar BN, Miller JS, Shet A, Verfaillie CM. Novel therapies for chronic myelogenous leukemia. Experimental Hematology 2001; 29: 543-555. Jiang Y, Jahagirdar BN (equal contribution first author), Schwartz RE, Reyes M, Reinhardt R Lee, Chang Hui-Chu, Lenvik T, Lund T, Blackstedt M, Du J, Aldrich S, Lisberg A, Largaespada DA, Verfaillie CM. Pluripotent nature of adult marrow derived mesenchymal stem cells. Nature 2002; 418(6893): 41-49. Reyes M, Dudek A, Jahagirdar B, Koodie L, Verfaillie CM. Origin of endothelial progenitors in human post-natal bone marrow. J Clin Invest 2002; 109(3): 337-346.
Devine SM, Jahagirdar B, van Besien K. Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma. Blood 2002; 99(11): 4251-2.
Jahagirdar BN, VA Morrison VA. Emerging fungal infections in patients with hematologic malignancies. Semin Respir Infect 2002; 17: 113-120.
Shet A, Jahagirdar B, Verfaillie CM. Chronic myelogenous leukemia - mechanisms of disease progression. Leukemia 2002; 16(8): 1402-1411.
Reyes M, Schwartz R, Jahagirdar B, Jiang Y, Verfaillie CM. Multipotent adult progenitor cells. Frontiers in HematOncology 2002; 1(2): 4-7. Jahagirdar BN, Verfaillie CM. Multipotent adult progenitor cell and stem cell plasticity. Stem Cell Reviews 2005; 1(1): 53. Hussein K, Jahagirdar B, Gupta P, Burns L, Larsen K, Weisdorf D. Day-14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol 2008; 83(6): 446-450.
|
